Boundless Bio

Developer of therapeutics for cancer by targeting ecDNA

placeSan Diego, California, United States calendar_todayFounded 2018 groups29 employees language boundlessbio.com

Registered entities

Innovation

18 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 243 times.

YearFilings
20212
20223
20238
202415
20259
20264

Social engagement

Social engagement: 7.9K social following, 5 posts in the last 12 months — above the industry median.

Investor mix

21 investors on record; lead investors include Nextech Invest, RA Capital Management, Arch Venture Partners, Bayer.

Investor typeCountShare
Venture capital629%
Private equity314%
Bank & private debt210%
Other / undisclosed1048%

Recent activity

2 Dec 2025
Event
San Antonio Breast Cancer Symposium
24 Nov 2025
Event
Piper Sandler 37th Annual Healthcare Conference
13 Oct 2025
Event
AACREORTC conference
Coming soon